Literature DB >> 23609018

Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain.

Raphaëlle Caillierez1, Séverine Bégard, Katia Lécolle, Vincent Deramecourt, Nadège Zommer, Simon Dujardin, Anne Loyens, Noëlle Dufour, Gwennaëlle Aurégan, Joris Winderickx, Philippe Hantraye, Nicole Déglon, Luc Buée, Morvane Colin.   

Abstract

Most models for tauopathy use a mutated form of the Tau gene, MAPT, that is found in frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) and that leads to rapid neurofibrillary degeneration (NFD). Use of a wild-type (WT) form of human Tau protein to model the aggregation and associated neurodegenerative processes of Tau in the mouse brain has thus far been unsuccessful. In the present study, we generated an original "sporadic tauopathy-like" model in the rat hippocampus, encoding six Tau isoforms as found in humans, using lentiviral vectors (LVs) for the delivery of a human WT Tau. The overexpression of human WT Tau in pyramidal neurons resulted in NFD, the morphological characteristics and kinetics of which reflected the slow and sporadic neurodegenerative processes observed in sporadic tauopathies, unlike the rapid neurodegenerative processes leading to cell death and ghost tangles triggered by the FTDP-17 mutant Tau P301L. This new model highlights differences in the molecular and cellular mechanisms underlying the pathological processes induced by WT and mutant Tau and suggests that preference should be given to animal models using WT Tau in the quest to understand sporadic tauopathies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23609018      PMCID: PMC3702115          DOI: 10.1038/mt.2013.66

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  52 in total

1.  Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.

Authors:  Preeti J Khandelwal; Sonya B Dumanis; Alexander M Herman; G William Rebeck; Charbel E-H Moussa
Journal:  Mol Cell Neurosci       Date:  2011-09-14       Impact factor: 4.314

2.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.

Authors:  A Probst; J Götz; K H Wiederhold; M Tolnay; C Mistl; A L Jaton; M Hong; T Ishihara; V M Lee; J Q Trojanowski; R Jakes; R A Crowther; M G Spillantini; K Bürki; M Goedert
Journal:  Acta Neuropathol       Date:  2000-05       Impact factor: 17.088

Review 3.  Adeno-associated virus vectors: activity and applications in the CNS.

Authors:  A L Peel; R L Klein
Journal:  J Neurosci Methods       Date:  2000-06-01       Impact factor: 2.390

4.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

5.  Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies.

Authors:  Jozef Hanes; Norbert Zilka; Miriam Bartkova; Miroslava Caletkova; Dusan Dobrota; Michal Novak
Journal:  J Neurochem       Date:  2009-01-07       Impact factor: 5.372

6.  Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study.

Authors:  G Lace; G M Savva; G Forster; R de Silva; C Brayne; F E Matthews; J J Barclay; L Dakin; P G Ince; S B Wharton
Journal:  Brain       Date:  2009-03-24       Impact factor: 13.501

7.  Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.

Authors:  Karelle Leroy; Alexis Bretteville; Katharina Schindowski; Emmanuel Gilissen; Michèle Authelet; Robert De Decker; Zehra Yilmaz; Luc Buée; Jean-Pierre Brion
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

8.  Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer.

Authors:  Ronald L Klein; Robert D Dayton; Cynthia G Diaczynsky; David B Wang
Journal:  Neurobiol Aging       Date:  2009-01-19       Impact factor: 4.673

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

View more
  18 in total

1.  Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.

Authors:  Dave J Koss; Lianne Robinson; Anna Mietelska-Porowska; Anna Gasiorowska; Kristina Sepčić; Tom Turk; Marcel Jaspars; Grazyna Niewiadomska; Roderick H Scott; Bettina Platt; Gernot Riedel
Journal:  Cell Mol Life Sci       Date:  2015-06-13       Impact factor: 9.261

2.  Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics.

Authors:  Joëlle Rosseels; Jeff Van den Brande; Marie Violet; Dirk Jacobs; Pierre Grognet; Juan Lopez; Isabelle Huvent; Marina Caldara; Erwin Swinnen; Anthony Papegaey; Raphaëlle Caillierez; Valerie Buée-Scherrer; Sebastiaan Engelborghs; Guy Lippens; Morvane Colin; Luc Buée; Marie-Christine Galas; Eugeen Vanmechelen; Joris Winderickx
Journal:  J Biol Chem       Date:  2014-12-24       Impact factor: 5.157

3.  Human wildtype tau expression in cholinergic pedunculopontine tegmental neurons is sufficient to produce PSP-like behavioural deficits and neuropathology.

Authors:  Gabriella King; Kaliana M Veros; Duncan Archibald Allan MacLaren; Martin Peter Konrad Leigh; Joseph A Spernyak; Stewart D Clark
Journal:  Eur J Neurosci       Date:  2021-11-02       Impact factor: 3.698

4.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

5.  The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro.

Authors:  Alison Spilsbury; Satomi Miwa; Johannes Attems; Gabriele Saretzki
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

Review 6.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

7.  Neuronal activity enhances tau propagation and tau pathology in vivo.

Authors:  Jessica W Wu; S Abid Hussaini; Isle M Bastille; Gustavo A Rodriguez; Ana Mrejeru; Kelly Rilett; David W Sanders; Casey Cook; Hongjun Fu; Rick A C M Boonen; Mathieu Herman; Eden Nahmani; Sheina Emrani; Y Helen Figueroa; Marc I Diamond; Catherine L Clelland; Selina Wray; Karen E Duff
Journal:  Nat Neurosci       Date:  2016-06-20       Impact factor: 24.884

Review 8.  Practical considerations for choosing a mouse model of Alzheimer's disease.

Authors:  Joanna L Jankowsky; Hui Zheng
Journal:  Mol Neurodegener       Date:  2017-12-22       Impact factor: 14.195

9.  Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies.

Authors:  Simon Dujardin; Katia Lécolle; Raphaëlle Caillierez; Séverine Bégard; Nadège Zommer; Cédrick Lachaud; Sébastien Carrier; Noëlle Dufour; Gwennaëlle Aurégan; Joris Winderickx; Philippe Hantraye; Nicole Déglon; Morvane Colin; Luc Buée
Journal:  Acta Neuropathol Commun       Date:  2014-01-30       Impact factor: 7.801

10.  Ectosomes: a new mechanism for non-exosomal secretion of tau protein.

Authors:  Simon Dujardin; Séverine Bégard; Raphaëlle Caillierez; Cédrick Lachaud; Lucie Delattre; Sébastien Carrier; Anne Loyens; Marie-Christine Galas; Luc Bousset; Ronald Melki; Gwennaëlle Aurégan; Philippe Hantraye; Emmanuel Brouillet; Luc Buée; Morvane Colin
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.